What's in UNC Lineberger Comprehensive Cancer Center's pipeline?

UNC Lineberger Comprehensive Cancer Center has 4 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 2 in Phase 1.

Which companies overlap with UNC Lineberger Comprehensive Cancer Center's portfolio?

Top competitors by shared drug class: AstraZeneca, Bracco Diagnostics, Inc, Centre Hospitalier Régional Metz-Thionville, Centre Leon Berard, Children's Hospital of Philadelphia.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/unc-lineberger-comprehensive-cancer-center.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

UNC Lineberger Comprehensive Cancer Center — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

UNC Lineberger Comprehensive Cancer Center pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Perflutren lipid	Perflutren lipid	marketed	Ultrasound contrast agent		Diagnostic Imaging
XL092	XL092	phase 3	CDK4/6 inhibitor	CDK4/6	Oncology

Therapeutic area mix

Diagnostic Imaging · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 1 shared drug class
Bracco Diagnostics, Inc · 1 shared drug class
Centre Hospitalier Régional Metz-Thionville · 1 shared drug class
Centre Leon Berard · 1 shared drug class
Children's Hospital of Philadelphia · 1 shared drug class
Draig Therapeutics Ltd · 1 shared drug class
Fujian Cancer Hospital · 1 shared drug class
Acusphere · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for UNC Lineberger Comprehensive Cancer Center:

Cite this brief

Drug Landscape (2026). UNC Lineberger Comprehensive Cancer Center — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/unc-lineberger-comprehensive-cancer-center. Accessed 2026-05-16.